{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~19 mi. (Ontario, Oregon, +523 more cities)
facility
Saint Alphonsus Medical Center-Ontario
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
~19 mi. (Ontario, Oregon, +233 more cities)
facility
Saint Alphonsus Medical Center-Ontario
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~19 mi. (Ontario, Oregon, +825 more cities)
facility
Saint Alphonsus Medical Center-Ontario
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~19 mi. (Ontario, Oregon, +240 more cities)
facility
Saint Alphonsus Medical Center-Ontario
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~19 mi. (Ontario, Oregon, +327 more cities)
facility
Saint Alphonsus Medical Center-Ontario
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types